Dermairol en es it fr

Dermairol Brand names, Dermairol Analogs

Dermairol Brand Names Mixture

  • No information avaliable

Dermairol Chemical_Formula


Dermairol RX_link

Dermairol fda sheet

Dermairol FDA

Dermairol msds (material safety sheet)

Dermairol MSDS

Dermairol Synthesis Reference

Matsui et al.; J.Vitaminol.; 4; 190, 192(1958)

Dermairol Molecular Weight

300.435 g/mol

Dermairol Melting Point

181 oC

Dermairol H2O Solubility

<0.1 g/100 mL

Dermairol State


Dermairol LogP


Dermairol Dosage Forms

Capsule; Cream; Gel; Liquid

Dermairol Indication

For the the induction of remission in patients with acute promyelocytic leukemia (APL), French-American-British (FAB) classification M3 (including the M3 variant); For the topical treatment of acne vulgaris, flat warts and other skin conditions (psoriasis, ichthyosis congenita, icthyosis vulgaris, lamellar icthyosis, keratosis palmaris et plantaris, epidermolytic hyperkeratosis, senile comedones, senile keratosis, keratosis follicularis (Darier's disease), and basal cell carcinomas.); For palliative therapy to improve fine wrinkling, mottled hyperpigmentation, roughness associated with photodamage.

Dermairol Pharmacology

Tretinoin, also known as all-trans-retinoic acid (ATRA), is a naturally occurring derivative of vitamin A (retinol). Retinoids such as tretinoin are important regulators of cell reproduction, proliferation, and differentiation and are used to treat acne and photodamaged skin and to manage keratinization disorders such as ichthyosis and keratosis follicularis. Tretinoin also represents the class of anticancer drugs called differentiating agents and is used in the treatment of acute promyelocytic leukemia (APL).

Dermairol Absorption

1-31% (topical);

Dermairol side effects and Toxicity

No information avaliable

Dermairol Patient Information

No information avaliable

Dermairol Organisms Affected

Humans and other mammals